Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1995-06-05
1997-05-27
Kight, John
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
53612312, 536124, 536127, C07H 100, C07H 106, C08B 3700, A61K 31715
Patent
active
056333692
ABSTRACT:
A method for producing soluble preparations of neutral glucan polymers is disclosed. The method involves treating whole glucan particles with a unique sequence of acid and alkaline treatments to produce soluble glucan. The soluble glucan can be purified to obtain a physiologically acceptable solution of neutral glucan molecules. A soluble neutral glucan preparation is obtained which forms a clear solution at a neutral pH and is equilibrated in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 3943247 (1976-03-01), Komatsu et al.
patent: 4138479 (1979-02-01), Truscheit et al.
patent: 4237266 (1980-12-01), Sugiura et al.
patent: 4707471 (1987-11-01), Larm et al.
patent: 4739046 (1988-04-01), DiLuzio et al.
patent: 4761402 (1988-08-01), Williams et al.
patent: 4810646 (1989-03-01), Jamas et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5320849 (1994-06-01), Hagiwara et al.
patent: 5322841 (1994-06-01), Jamas et al.
Fleet et al., Chemical Abstracts, 85:89819z (1976).
Bacon et al., Biochem. J., 114: 557-567 (1969).
Manners et al., Biochem. J., 135: 19-30 (1973).
Williams et al., Chemical Abstracts, 109: 66566q (1988).
Janusz, M.J. et al., "Isolation of Soluble Yeast .beta.-Glucans That Inhibit Human Monocyte Phagocytosis Mediated by .beta.-Glucan Receptors," J. Immunol. 137: 3270-3276 (Nov. 15, 1986).
Manners, D.J. et al., "The Structure of a .beta.-(1.fwdarw.3)-D-Glucan from Yeast Cell Walls," Biochem. J. 135: 19-30 (1973).
Fleet, G.H., et al., "Isolation and Composition of an Alkali-Soluble Glucan from the Cell Walls of Saccharomyces cerevisiae," Journal of General Microbiology, 94: 180-192 (1976).
Miyazaki, T., et al., "Structural Examination of Antitumour, Water-Soluble Glucans from Grifora umbellata by Use of Four Types of Glucanase," Carbohydrate Research, 65: 235-243 (1978).
Reiskind, J.B. and Mullins, J.T., "Molecular Architecture of the Hyphal Wall of Achlya ambisexualis Raper. II. Ultrastructural Analyses and a Proposed Model," Can. J. Microbiol., 27: 1100-1105 (1981).
Latg e, J.P. et al., "Composition Chimique et Ultrastructure des Parois des Corps Hyphaux et des Azygospores de Conidiobolus obscurus," Can. J. Microbiol., 30: 1507-1521 (1984).
Sherwood, E.R. et al., "Soluble Glucan and Lymphokine-Activated Killer (LAK) Cells in the Therapy of Experimental Hepatic Metastases," Chemical Abstracts 108: 179752v (1988).
Hara, C. et al., "A Branched (1.fwdarw.3)-.beta.-D-Glucan from a Water Extract of Dictyophora indusiata FISCH," Carb. Res. 145: 237-246 (1986).
Goldman, R., "Induction of a .beta.-1,3-D-Glucan Receptor in P388D1 Cells Treated with Retinoic Acid of 1,25-dihydroxyvitamin D.sub.3," Immunology 63: 319-324 (1988).
Konopski, A. et al., "Phagocytosis of .beta.-1,3-D-Glucan-Derivatized Microbeads by Mouse Peritoneal Macrophages Involves Three Different Receptors," Scand. J. Immunol. 33: 297-306 (1991).
Bacon, J. et al., "The Glucan Components of the Cell Wall of Baker's Yeast (Saccharomyces cerevisiae) Considered in Relation to its Ultrastructure," Biochem. J. 114: 557-567 (1969).
Vestnik Federalniho Uradu Pro Vynalezy 10: 111 (1989).
Vestnik Federalniho Uradu Pro Vynalezy 11: 122-123 (1989).
Abel, G. and J.K. Czop, "Activation of Human Monocyte GM-CSF and TNF-.alpha. Production by Particulate Yeast Glucan," International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Chihara, G. et al., "Lentinan as a Host Defense Potentiator (HPD)," Int. J. Immunotherapy V(4): 145-154 (1989).
Sherwood, E.R. et al., "Enhancement of Interleukin-1 and Interleukin-2 Production by Soluble Glucan," Int. J. Immunopharm. 9(3): 261-267 (1987).
Williams, D.L. et al., "Pre-Clinical Safety Evaluation of Soluble Glucan," Int. J. Immunopharmac. 10(4): 405-414 (1988).
Browder, W. et al., "Beneficial Effect of Enhanced Macrophage Function in the Trauma Patient," Ann. Surg. pp. 605-613 (1990).
Shiota, M. et al., "Comparison of .beta.-Glucan Structures in a Cell Wall Mutant of Saccharomyces cerevisiae and the Wild Type", J. Biochem. 98:1301-1307 (1985).
Jamas et al., "PGG-A Novel Class of Macrophage Activating Immunomodulators", International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Katzen et al., "PGG, A Glucose Polymer, Primes Interleukin-1 and Tumor Necrosis Factor Production . . . ", International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Shah et al. "Influence of PGG on the Phagocytosis of Staphylococcus aureus or Escherichia coli . . . " International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Onderdonk, A.B., "Effect of a New Carbohydrate Polymer on Survival in a Mouse Model for Experimental E. coli sepsis", International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
A. Arbo and J.I. Santos, "Effect of PGG on Neutrophil (PMN) Function in Experimental Malnutrition", International Congress for Infectious Diseases, Montreal Canada (Abstract), Jul. 15-19, 1990.
Easson, Jr. D. Davidson
Jamas Spiros
Ostroff Gary R.
Alpha-Beta Technology, Inc.
Kight John
White Everett
LandOfFree
Method for producing soluble glucans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing soluble glucans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing soluble glucans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2330085